Verve Therapeutics Stock Prediction

On average, they anticipate verve therapeutics' stock price to reach $71.20 in the next year. Buy or sell verve therapeutics stock?

424b4

The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe verv will outperform the market and that investors should add to their positions of verve therapeutics.

Verve therapeutics stock prediction. Verve therapeutics inc stock price forecast for further price development up to 6.55% (time horizon: Verve therapeutics inc () stock market info recommendations: The company traded as low as $30.89 and last traded at $31.41.

The stock's lowest day price was 33.15. The biotech stock, which was as low as $41.52 a share on monday, climbed as high as $48.39 by thursday. Verve therapeutics currently has 2 hold ratings and 3 buy ratings from wall street analysts.

The average price target for verv set by the institutional analysts is $73.78 where high estimate is $88.20, median $76.5 and low $58.58. Wall street stock market & finance report, prediction for the future: Verv stock forecast our latest prediction for verve therapeutics inc's stock price was made on the dec.

During the day the stock fluctuated 4.56% from a day low at $47.35 to a day high of $49.51. View the latest ratings for verv. 2, 2021 when the stock price was at 32.94$.

Verve therapeutics is followed by the analysts listed above. Verve therapeutics is selling for under 33.15 as of the 28th of november 2021; Barron’s reported on 11/12/21 that gene editor verve unveils second wa

As stock downgraded to sell candidate. And has now fallen 8 days in a row. Approximately 9,162 shares changed hands during trading, a decline of 98% from the average daily volume of 401,011 shares.

Verve therapeutics started at hold with $58 stock price target at stifel nicolaus. The verve therapeutics stock forecast is 36.320967610993 usd for 2022 december 02,. The average verve therapeutics stock price prediction forecasts a potential downside of n/a from the current verv share price of $41.28.

In the medium term (3months), verv's stock price should underperform the. This suggests a possible upside of 72.4% from the stock's current price. Get the latest verve therapeutics, inc.

As of 2021 november 25, thursday current price of docs stock is 59.430$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). About verve therapeutics verve therapeutics, inc. Verve therapeutics inc stock price forecast, verv predictons for2021.

Their forecasts range from $50.00 to $92.00. Please note that any opinions, estimates or forecasts regarding verve therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of. The average price target for verv by institutional analysts is $.

Verv) is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to. Weaker technical forecast for verve therapeutics, inc. 24, 2021 at 8:00 a.m.

Verve therapeutics's share price could stay at $66.67 by sep 24, 2022. Verv) is up 16.5% for the week. Verve therapeutics inc (verv) stock price prediction by analysts.

(nasdaq:verv) shares, rose in value on wednesday, 11/24/21, with the stock price up by 1.94% to the previous day’s close as strong business analysts predict comsovereign holding corp. On june 21, 2021, we completed our ipo in which we issued and sold an aggregate of 16,141,157 shares of our common stock, including 2,105,368 shares of common stock sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a public offering price of $19.00 per share, for aggregate net proceeds of $281.6. On average, wall street analysts predict that.

Verv investment & stock information. 1 day) and price target of 47.42 usd. Verve therapeutics (verv) stock price prediction is 36.320967610993 usd.

Get the latest verve therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including verve stock investment advice, charts, stats and more. Insiders wellington management and casdin capital and new investor fidelity have indicated an interest in purchasing up to an aggregate $75 million. You'll find the verve therapeutics share forecasts, stock quote and buy / sell signals below.according to present data verve therapeutics's verv shares and potentially its market environment have been in a bullish cycle in the.

According to the issued ratings of 5 analysts in the last year, the consensus rating for verve therapeutics stock is buy based on the current 2 hold ratings and 3 buy ratings for verv. (nasdaq:verv)s stock price dropped 5.7% on thursday.

Roth Ch Acquisition I Stock Forecast Up To 55185 Usd - Roch Stock Price Prediction Long-term Short-term Share Revenue Prognosis With Smart Technical Analysis

S-1

S-1

3 Biotech Stocks That Could Be Millionaire-makers Nasdaq

Verve Therapeutics Battling Bad Cholesterol With Single Treatment Nasdaq

Pc0h3jcpn1g1am

Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq

Us Stock Market Stock Forecast Us Stock Price Predictions With Smart Prognosis Chart 2021-2022

Ideas And Forecasts On Verve Therapeutics Inc Nasdaqverv Tradingview

S-1

Verve Therapeutics - Headquarter Locations Competitors Financials Employees

Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq

S-1

Verve Therapeutics Explodes Out Of Stealth Mode To Focus On Gene Therapies For Cardiovascular Disease Biospace

Verve Therapeutics A Gene Editing Crispr Company Focused On Curing Heart Disease Files For Ipo Rbiotechplays

Verve Therapeutics Stock Analysis Verv Stock Rating - Tipranks

Verve Therapeutics Stock Forecast Down To 14875 Usd - Verv Stock Price Prediction Long-term Short-term Share Revenue Prognosis With Smart Technical Analysis

Verves Shares Soar As Cambridge Biotech Makes Its Stock Market Debut - The Boston Globe

Verv Stock Forecast Price News Verve Therapeutics